CINXE.COM

<!DOCTYPE html> <html lang="en"> <head> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <link rel="alternate" href="https://www.alliedacademies.org/" hreflang="en" /> <link rel="canonical" href="https://www.alliedacademies.org/articles/immune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html"> <link rel="shortcut icon" href="https://www.alliedacademies.org/images/favicon.ico"/>  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/jqueryui/1.12.1/jquery-ui.css" /> <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/css/bootstrap.min.css"> <link href="https://fonts.googleapis.com/css?family=Open+Sans:300,300i,400,400i,600,600i,700,700i,800,800i" rel="stylesheet"> <link href="https://fonts.googleapis.com/css?family=Catamaran:100,200,300,400,500,600,700,800,900" rel="stylesheet"> <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/animate.css/3.5.2/animate.min.css" /> <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.7.1/css/all.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/css/metisMenu.min.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/css/dzsparallaxer.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/assets/css/icons.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/assets/css/author.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/css/global.css"> <link rel="stylesheet" href="https://www.alliedacademies.org/css/styles.css">   <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8046643215361735" crossorigin="anonymous"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-Q6TCJGJW4D"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-Q6TCJGJW4D'); </script> <title> Immune checkpoint inhibitors (ICIs) in cancer immunotherapy </title> <meta name="keywords" content=""> <meta name="description" content=".. "> <meta name="citation_publisher" content="Allied Academies"/> <meta name="citation_journal_title" content="Immunology Case Reports"> <meta name="citation_title" content="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy"> <meta name="citation_author" content="Abdul Reza"/> <meta name="citation_year" content="2023"> <meta name="citation_volume" content="6"> <meta name="citation_issue" content="4"> <meta name="citation_doi" content="10.35841/aaicr-6.4.161"> <meta name="citation_issn" content="Open Access"> <meta name="citation_publication_date" content=""/> <meta name="citation_abstract" content=""> <meta name="citation_fulltext_html_url" content="https://www.alliedacademies.org/articles/immune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html"> <meta name="citation_pdf_url" content="https://www.alliedacademies.org/articles/immune-checkpoint-inhibitors-icis-in-cancer-immunotherapy.pdf"> <meta name="citation_abstract_html_url" content="https://www.alliedacademies.org/abstract/"> <script type="text/javascript"> function openimage(theURL, winName, features) { window.open(theURL, winName, features); } </script> </head> <body class="border-top-3 border-danger"> <svg class="d-none"> <defs> <path id="tabshape" d="M80,60C34,53.5,64.417,0,0,0v60H80z"/> </defs> </svg> <header> <nav class="navbar navbar-expand-lg navbar-light"> <div class="container"> <a class="navbar-brand w-xs-50" href="https://www.alliedacademies.org/" title="Allied Academies"> <img src="https://www.alliedacademies.org/images/allied-academies-logo.png" alt="" class="max-height-60 img-fluid"> </a> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#mainNav" aria-controls="mainNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="collapse navbar-collapse justify-content-end" id="mainNav"> <div class="navbar-nav"> <a class="nav-item nav-link active" href="https://www.alliedacademies.org/" title="Allied Academies">Home</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/journals.php" title="A-Z Journals">A-Z Journals</a> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="About" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" title="About"> About </a> <div class="dropdown-menu animated fadeInUp" aria-labelledby="About"> <a class="dropdown-item" href="https://www.alliedacademies.org/#" title="FAQs">FAQs</a> <a class="dropdown-item" href="https://www.alliedacademies.org/history.php" title="History">History</a> </div> </li> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="GuidelinesPolicies" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" title="Guidelines and Policies"> Guidelines & Policies </a> <div class="dropdown-menu animated fadeInUp" aria-labelledby="GuidelinesPolicies"> <a class="dropdown-item" href="https://www.alliedacademies.org/publication-policies-and-procedures.php" title="Publication Policies and Procedures">Publication Policies and Procedures</a> <a class="dropdown-item" href="https://www.alliedacademies.org/publication-guidelines.php" title="Publication Guidelines">Publication Guidelines</a> <a class="dropdown-item" href="https://www.alliedacademies.org/journal-submission-instructions.php" title="Journal Submission Instructions">Journal Submission Instructions</a> <a class="dropdown-item" href="https://www.alliedacademies.org/code-of-conduct.php" title="Code of Conduct">Code of Conduct</a> <a class="dropdown-item" href="https://www.alliedacademies.org/ethics.php" title="Ethics">Ethics</a> </div> </li> <a class="nav-item nav-link" href="https://www.alliedacademies.org/contact.php" title="Contact">Contact</a> <div id="google_translate_element" align="center" style="width:180px;"></div> <script> function googleTranslateElementInit() { new google.translate.TranslateElement( { pageLanguage: 'en' }, 'google_translate_element' ); } </script> <script src="https://translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script> </div> </div> </div> </nav> <section class="bg-grey-200"> <div class="container py-4"> <div class="row align-items-center justify-content-between"> <div class="col-12 col-sm-12"> <h2 class="text-danger mb-0 font-size-26 fweight-500">Immunology Case Reports</h2> </div>  </div> </div> </section>  <div class="container"> <div class="media alert alert-primary mt-3"> <i class="fas fa-hand-point-right fa-2x align-self-center mr-3 animated infinite bounce slow blue-500"></i> <div class="media-body"> All submissions of the EM system will be redirected to <strong>Online Manuscript Submission System</strong>. Authors are requested to submit articles directly to <a href="https://www.scholarscentral.org/submissions/immunology-case-reports.html" target="_blank" class="text-warning" title="Online Manuscript Submission System"><strong>Online Manuscript Submission System</strong></a> of respective journal. </div> </div> </div>  </header>  <div class="phonering-alo-phone phonering-alo-green phonering-alo-show bg-primary p-2 rounded-right" id="feedback"> <div class="phonering-alo-ph-circle"></div> Reach Us <img src="https://www.imedpub.com/images/telephone-white.svg" alt="" width="20" class="ml-2"> <img src="https://www.imedpub.com/images/whatsapp.svg" alt="" width="20" class="ml-2"> +1 (202) 780-3397 </div> <section class="py-4"> <div class="container"> <div class="row"> <main class="col-xs-12 col-sm-9"> <div class="card border-5 rounded-0"> <article class="card-body full-text"> <p class="grey-600 mb-1"><i class="fa fa-caret-right" aria-hidden="true"></i> Opinion Article - Immunology Case Reports (2023) Volume 6, Issue 4</p> <h1 class="text-danger font-size-26 fweight-400">Immune checkpoint inhibitors (ICIs) in cancer immunotherapy</h1> <p><strong>Abdul Reza<sup><a href="#corr">*</a></sup></strong></p> <p>Department of Immunology, Iran University of Medical Sciences, Iran</p> <dl class="dl-horizontal"> <dt>*Corresponding Author:</dt> <dd>Abdul Reza<a name="corr" id="corr"></a> <br /> Department of Immunology<br /> Iran University of Medical Sciences<br /> Iran<br /> <strong>E-mail:</strong>rabdul@iums.ac.ir</dd> </dl> <p><strong>Received</strong><strong>:</strong>30-July-2023, Manuscript No. AAICR-23-109013; <strong>Editor assigned</strong><strong>:</strong>04-Aug-2023, PreQC No. AAICR-23-109013(PQ); <strong>Reviewed</strong><strong>:</strong>18-Aug-2023, QC No. AAICR-23-109013; <strong>Revised:</strong>24-Aug-2023, Manuscript No. AAICR-23-109013(R); <strong>Published:</strong>31-Aug-2023, DOI:10.35841/aaicr-6.4.161</p> <p><strong>Citation: </strong>Reza A. Immune checkpoint inhibitors (ICIs) in <a target='_blank' href='https://www.alliedacademies.org/scientific-journals/cancer-28.html'>cancer</a> immunotherapy. Immunol Case Rep. 2023;6(4):161</p> <div> <strong>Visit for more related articles at </strong> <a href="https://www.alliedacademies.org/immunology-case-reports/volume-selector.php" title="Immunology Case Reports"> Immunology Case Reports </a> </div> <h2 class="post-title">Introduction</h2> <p>Cancer remains one of the most formidable challenges in the field of medicine, affecting millions of lives worldwide. Despite significant advancements in conventional treatments such as surgery, chemotherapy, and radiation therapy, a considerable number of cancer patients face limited treatment options and poor prognosis. In recent years, the emergence of cancer immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized the oncology landscape by harnessing the body's immune system to fight cancer. This article explores the concept of ICIs, their mechanisms of action, and their significant impact on cancer treatment [<a href="#1" title="1">1</a>].</p> <h2 class="post-title">Role of immune checkpoints in cancer</h2> <p>The immune system is a complex network of cells and molecules that work together to recognize and eliminate abnormal cells, including cancer cells. However, cancer cells have evolved various mechanisms to evade the immune system's surveillance and attack, allowing them to grow and spread uncontrollably. One such mechanism involves the activation of immune checkpoints. Immune checkpoints are pathways in the immune system that help regulate the immune response and maintain self-tolerance to avoid attacking healthy tissues. These checkpoints, such as programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), play a crucial role in preventing excessive immune responses that could lead to autoimmunity. Cancer cells often exploit these checkpoints by upregulating certain proteins like PD-L1, which binds to PD-1 on T cells, inhibiting their function and preventing them from attacking the tumor cells. As a result, the immune system becomes less effective in recognizing and destroying cancer cells, leading to tumor growth and disease progression [<a href="#2" title="2">2</a>].</p> <h2 class="post-title">Birth of immune checkpoint inhibitors</h2> <p>ICIs are a class of drugs that aim to reverse the immune evasion mechanisms employed by cancer cells. They work by blocking the interactions between immune checkpoints and their ligands, effectively reactivating the immune system's ability to recognize and attack cancer cells. Monoclonal antibodies are the most common form of immune checkpoint inhibitors. The first FDA-approved ICI was ipilimumab, a CTLA-4 inhibitor, which received approval in 2011 for the treatment of metastatic melanoma. Since then, several other ICIs have been developed and approved for various types of cancer, providing new hope for patients with previously limited treatment options. ICIs primarily target three key immune checkpoint pathways are PD-1/PD-L1, CTLA-4, and others like LAG-3, TIM-3, and IDO. By blocking these pathways, ICIs unleash the immune system's potential, enhancing the anti-tumor immune response. Drugs such as pembrolizumab and nivolumab target the PD-1 receptor or its ligand, PD-L1. By blocking PD-1/PD-L1 interactions, these drugs prevent the cancer cells from deactivating T cells, allowing them to recognize and attack the tumor. Ipilimumab is the first-in-class CTLA-4 inhibitor that disrupts the interaction between CTLA-4 and its ligands on antigen-presenting cells, enhancing the activation and proliferation of T cells. Emerging therapies target additional immune checkpoints like LAG-3, TIM-3, and IDO to further improve the immune response against cancer cells [<a href="#3" title="3">3</a>].</p> <h2 class="post-title">Clinical applications and successes</h2> <p>ICIs have demonstrated remarkable efficacy across various cancer types, leading to durable responses and long-term survival in some patients. These agents have been particularly successful in treating melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma, and Hodgkin's lymphoma. In addition to standalone use, researchers are exploring combination therapies, using ICIs in conjunction with other immunotherapies or traditional treatments, to further enhance their effectiveness. Combinations of ICIs with chemotherapy, targeted therapies, and radiation therapy are being investigated in ongoing clinical trials [<a href="#4" title="4">4</a>].</p> <p>Despite the tremendous success of ICIs, challenges remain. Not all patients respond to these therapies, and resistance to ICIs can develop over time. Identifying biomarkers that can predict treatment response and resistance is a crucial area of research. Moreover, ICIs can lead to immune-related adverse events (irAEs) due to the uncontrolled activation of the immune system. These irAEs can affect various organs and require careful management and monitoring. In the future, ongoing research will focus on expanding the use of ICIs to other cancer types, identifying novel targets for combination therapies, and developing personalized approaches to maximize treatment efficacy while minimizing adverse effects [<a href="#5" title="5">5</a>].</p> <h2 class="post-title">Conclusion</h2> <p>Despite the tremendous success of ICIs, challenges remain. Not all patients respond to these therapies, and resistance to ICIs can develop over time. Identifying biomarkers that can predict treatment response and resistance is a crucial area of research. Moreover, ICIs can lead to immune-related adverse events (irAEs) due to the uncontrolled activation of the immune system. These irAEs can affect various organs and require careful management and monitoring. In the future, ongoing research will focus on expanding the use of ICIs to other cancer types, identifying novel targets for combination therapies, and developing personalized approaches to maximize treatment efficacy while minimizing adverse effects.</p>  <h2 class="post-title">References</h2> <ol> <li><a name="1" id="1"></a>Naidoo J, Page DB, Li BT, et al. <a href="https://www.sciencedirect.com/science/article/pii/S0923753419357151" target="_blank">Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies</a>. Ann Oncol. 2015;26(12):2375-91.<strong> </strong></li> <p target="_blank" align="right"><a href="https://pubmed.ncbi.nlm.nih.gov/26371282/" target="_blank"><u>Indexed at</u></a>, <a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=1.%09Naidoo+J%2C+Page+DB%2C+Li+BT%2C+et+al.+Toxicities+of+the+anti-PD-1+and+anti-PD-L1+immune+checkpoint+antibodies.+Ann+Oncol.+2015%3B26%2812%29%3A2375-91&btnG=" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1093/annonc/mdv383" target="_blank"><u>Cross Ref</u></a></p> <li><a name="2" id="2"></a>Nicolas-Boluda A, Vaquero J, Vimeux L, et al. <a href="https://elifesciences.org/articles/58688" target="_blank">Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment</a>. Elife. 2021;10:e58688.<strong> </strong></li> <p target="_blank" align="right"><a href="https://pubmed.ncbi.nlm.nih.gov/34106045/" target="_blank"><u>Indexed at</u></a>, <a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=2.%09Nicolas-Boluda+A%2C+Vaquero+J%2C+Vimeux+L%2C+et+al.+Tumor+stiffening+reversion+through+collagen+crosslinking+inhibition+improves+T+cell+migration+and+anti-PD-1+treatment.+Elife.+2021%3B10%3Ae58688&btnG=" target="_blank"><u>Google Scholar</u></a>,<a href="https://doi.org/10.7554/elife.58688" target="_blank"><u>Cross Ref</u></a></p> <li><a name="3" id="3"></a>Nixon NA, Blais N, Ernst S, et al. <a href="https://www.mdpi.com/1718-7729/25/5/3840" target="_blank">Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges</a>. Current oncology. 2018;25(5):373-84.<strong> </strong></li> <p target="_blank" align="right"><a href="https://pubmed.ncbi.nlm.nih.gov/30464687/" target="_blank"><u>Indexed at</u></a>, <a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=3.%09Nixon+NA%2C+Blais+N%2C+Ernst+S%2C+et+al.+Current+landscape+of+immunotherapy+in+the+treatment+of+solid+tumours%2C+with+future+opportunities+and+challenges.+Current+oncology.+2018%3B25%285%29%3A373-84&btnG=" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.3747/co.25.3840" target="_blank"><u>Cross Ref</u></a></p> <li><a name="4" id="4"></a>Pardoll DM. <a href="https://www.nature.com/articles/nrc3239" target="_blank">The blockade of immune checkpoints in cancer immunotherapy</a>. Nat Rev Cancer. 2012;12(4):252-64. <strong> </strong></li> <p target="_blank" align="right"><a href="https://pubmed.ncbi.nlm.nih.gov/22437870/" target="_blank"><u>Indexed at</u></a>, <a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=4.+Pardoll+DM.+The+blockade+of+immune+checkpoints+in+cancer+immunotherapy.+Nat+Rev+Cancer.+2012%3B12%284%29%3A252-64&btnG=" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1038/nrc3239" target="_blank"><u>Cross Ref</u></a></p> <li><a name="5" id="5"></a>Zandberg DP, Menk AV, Velez M, et al. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126285/" target="_blank">Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck</a>. . J Immunother Cancer. 2021;9(5). <strong> </strong></li> <p target="_blank" align="right"><a href="https://pubmed.ncbi.nlm.nih.gov/33986123/" target="_blank"><u>Indexed at</u></a>, <a href="https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=5.%09Zandberg+DP%2C+Menk+AV%2C+Velez+M%2C+et+al.+Tumor+hypoxia+is+associated+with+resistance+to+PD-1+blockade+in+squamous+cell+carcinoma+of+the+head+and+neck.+J+Immunother+Cancer.+2021%3B9%285%29&btnG='" target="_blank"><u>Google Scholar</u></a>, <a href="https://doi.org/10.1136/jitc-2020-002088" target="_blank"><u>Cross Ref</u></a></p> </ol> </article> </div> </main>  <aside class="col-12 col-sm-3 order-sm-1"> <a href="https://www.alliedacademies.org/journal-clinical-immunology-research-online-visitors-readers-75.html" class="btn btn-danger btn-block mb-3 font-size-4"><i class="fas fa-book-reader"></i> 25+ Million Readerbase</a> <a class="btn btn-danger btn-block mb-3 font-size-4" href="https://www.alliedacademies.org/immunology-case-reports/nominations.php" title="Awards & Nominations">Awards & Nominations</a>  <div class="text-center mb-3"> <a class="btn btn-outline-dark btn-sm" href="https://www.alliedacademies.org/articles/immune-checkpoint-inhibitors-icis-in-cancer-immunotherapy.pdf" title="View PDF"><i class="ti-eye"></i> View PDF</a> <a class="btn btn-outline-dark btn-sm" href="https://www.alliedacademies.org/download.php?download=articles/immune-checkpoint-inhibitors-icis-in-cancer-immunotherapy.pdf" title="Download PDF"><i class="ti-cloud-down"></i> Download PDF</a> </div> <div class="card shadow-sm sidebar mb-0"> <div class="list-group list-group-flush qr_code_image"> <img title="QR" src="https://chart.googleapis.com/chart?chs=185x185&cht=qr&chl=https%3A%2F%2Fwww.alliedacademies.org%2Farticles%2Fimmune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html&chld=M|0&icqrf=00b1e4" alt="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy" />  <nav class="nav nav-pills social-icons-footer sidebar_social_icons a-pl-0">        <a style="width:30px;" title="Share This Article" target="_blank" class="nav-link" href="https://www.facebook.com/sharer.php?s=100&p[title]=Immune checkpoint inhibitors (ICIs) in cancer immunotherapy&p[url]=https%3A%2F%2Fwww.alliedacademies.org%2Farticles%2Fimmune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html"><img src="https://www.alliedacademies.org/assets/socials/facebook.png" alt="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy" /></a>      <a style="width:30px;" target="_blank" href="https://web.whatsapp.com/send?text=https%3A%2F%2Fwww.alliedacademies.org%2Farticles%2Fimmune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html" title="Share This Article" class="nav-link"><img src="https://www.alliedacademies.org/assets/socials/whatsapp.png" alt="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy" /></a>      <a style="width:30px;" target="_blank" href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.alliedacademies.org%2Farticles%2Fimmune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html" title="Share This Article" class="nav-link"><img src="https://www.alliedacademies.org/assets/socials/linkedin.png" alt="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy" /></a>      <a style="width:30px;" title="Share This Article" target="_blank" href="https://twitter.com/share?text=Immune checkpoint inhibitors (ICIs) in cancer immunotherapy&url=https%3A%2F%2Fwww.alliedacademies.org%2Farticles%2Fimmune-checkpoint-inhibitors-icis-in-cancer-immunotherapy-26190.html" class="nav-link"><img src="https://www.alliedacademies.org/assets/socials/twitter.png" alt="Immune checkpoint inhibitors (ICIs) in cancer immunotherapy" /></a> </nav>  </div> </div> <div class="cu_navgation"> <nav class="sidebar-nav mb-3 p-0"> <a class="navbar-brand d-block d-sm-none" href="#">Journal Menu</a> <div> <div class="navbar-nav flex-column w-100"> <a class="nav-item nav-link active" href="https://www.alliedacademies.org/immunology-case-reports/" title="Journal Home">Journal Home</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/editors.php" title="Editorial Board"><i class="ti-id-badge"></i> Editorial Board</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/guidelines.php" title="Author Guidelines"><i class="ti-pencil-alt"></i> Author Guidelines</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/fast-editorial-review-process.php" title="Fast Editorial Review Process"><i class="ti-pencil-alt"></i> Fast Editorial Review Process</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/aimsandscope.php" title="Aim & Scope"><i class="ti-pencil-alt"></i> Aim & Scope</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/citations.php" title="Citations"><i class="ti-id-badge"></i> Citations</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/peer-review-process.php" title="Peer Review Process"><i class="ti-pencil-alt"></i> Peer Review Process</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/publication-ethics.php" title="Publication Ethics & Malpractice Statement"><i class="ti-pencil-alt"></i> Publication Ethics & Malpractice Statement</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/submit-manuscript.php" title="Submit Manuscript"><i class="ti-hand-point-up"></i> Submit Manuscript</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/inpress.php" title="In Press"><i class="ti-files"></i>Articles in process</a>  <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/special-issue.php" title="Special Issues"><i class="ti-layers-alt"></i> Special Issues</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/volume-selector.php" title="Volume Selector"><i class="ti-layers-alt"></i> Volume Selector</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/indexing.php" title="Indexing Services"><i class="ti-layers-alt"></i> Indexing Services</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports-advertising-39.html" title="Advertise"><i class="ti-files"></i> Advertise</a> <a class="nav-item nav-link" href="https://www.alliedacademies.org/covid-19-peer-reviewed-journals-articles-special-issues.php" title="Advertise"><i class="ti-layers-alt"></i> COVID-19 Special Issues</a> </div> </div> </nav> </div>  <h6><a target="_blank" href="https://scholar.google.com/citations?user=COeeF70AAAAJ&hl=en " title="Click here">Google Scholar citation report</a></h6> <h6 style="font-weight:bold;">Citations : 13</h6> <p><a target="_blank" href="https://scholar.google.com/citations?user=COeeF70AAAAJ&hl=en " title="Click here">Immunology Case Reports received 13 citations as per Google Scholar report</a></p> <div class="card shadow-sm sidebar mb-3"> <a href="https://www.alliedacademies.org/immunology-case-reports/citations.php" title="Click here"><img src="https://www.alliedacademies.org/admin/citation-images/immunology-case-reports-flyer.png" alt="Citation image" class="img-fluid p_rel" /></a> </div>     <h6><a href="https://publons.com/journal/106466/immunology-case-reports/" target="_blank" title="Click here">Immunology Case Reports peer review process verified by publons</a></h6> <div class="card shadow-sm sidebar mb-3"> <a href="https://publons.com/journal/106466/immunology-case-reports/" target="_blank" title="Click here"><img src="https://www.alliedacademies.org/admin/publon-images/immunology-case-reports-publon.png" alt="Publon image" height="200px" target="_blank" class="img-fluid p_rel" /></a> </div> <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header pr-0">Indexed In</h6> <div class="list-group list-group-flush"> <div class="p-0 pt-2 pl-2 index-view"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Publons<br> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Google Scholar<br> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Science Gate<br> </div> <a href="#" class="index-read-more"> <div class="card-footer"><a class="nav-item nav-link" href="https://www.alliedacademies.org/immunology-case-reports/indexing.php" title="Special Issues">Read More</a></div> </a> </div> </div>  <div class="card mb-3 radius-0 shadow-sm"> <div class="card-body font-size-18 radius-0 py-2 fweight-500"> Latest Volumes </div> <div class="card-header"> <select class="form-control" id="year" name="year"> <option value="2023" selected = selected > 2023</option> <option value="2022" > 2022</option> <option value="2021" > 2021</option> <option value="2020" > 2020</option> <option value="2019" > 2019</option> <option value="2018" > 2018</option> <option value="2017" > 2017</option> </select> </div> <div class="nav flex-column font-size-16 py-2" id="vol_disp"> </div> </div>  <div class="card mb-3"> <a href="https://www.alliedacademies.org/immunology-case-reports-advertising-39.html" title="Click here"><img src="https://www.alliedacademies.org/assets/images/tower-banner.jpg" alt="Flyer image" class="img-fluid p_rel" /> <span class="p_abo cu_roundchip"> <span> <h5><span>25+</span> Million Website Visitors</h5> <h5><span>4666+</span> Journal Visitors</h5> </span> </span> </a> </div>     <div class="card mb-3"> <a class="twitter-timeline" href="https://twitter.com/aaicr1" data-width="300" data-height="400">Tweets by aaicr1</a> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> </div>  <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header pr-0">Open Access Journals</h6> <div class="list-group list-group-flush"> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/chemistry-journals.php" title="Chemistry" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Chemistry</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/clinical-journals.php" title="Clinical Sciences" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Clinical Sciences</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/food-nutrition-journals.php" title="Food & Nutrition" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Food & Nutrition</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/general-science-journals.php" title="General Science" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>General Science</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/genetics-molecular-biology-journals.php" title="Genetics & Molecular Biology" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Genetics & Molecular Biology</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/immunology-microbiology-journals.php" title="Immunology & Microbiology" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Immunology & Microbiology</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/medical-journals.php" title="Medical Sciences" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Medical Sciences</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/neurology-psychology-journals.php" title="Neurology & Psychology" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Neurology & Psychology</a> </div> <div class="list-group-item p-0 pt-2 pl-2"> <a class="pr-2 deep-orange-400-before cu_bu" href="https://www.alliedacademies.org/nursing-health-care-journals.php" title="Nursing & Health Care" target="_blank"><span class="text-danger mr-1"><i class="far fa-hand-point-right"></i></span>Nursing & Health Care</a> </div> </div> </div>  </aside>  <script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js"></script> <script type="text/javascript"> $(document).ready(function() { $("#year").val('2023'); yearchange('2023'); $("#year").change(function() { var year=$("#year").val(); yearchange(year); }); function yearchange(year){ //var year=$("#year").val(); var journal="aaicr"; var dataString = {'year':year,'journal':journal}; $.ajax ({ type: "POST", url: "https://www.alliedacademies.org/vol_disp.php", data: dataString, cache: false, success: function(html) { $("#vol_disp").html(html); } }); } }); </script> </div> </div> </section> <footer class="bg-grey-800 font-size-14">  <a href="#0" class="cd-top js-cd-top"> <svg viewBox="0 0 80 60" preserveAspectRatio="none" class="back-to-top-svg"><use xlink:href="#tabshape"></use></svg> <svg viewBox="0 0 80 60" preserveAspectRatio="none" class="back-to-top-svg"><use xlink:href="#tabshape"></use></svg> <span><i class="fas fa-angle-up"></i></span> </a> <div class="container"> <div class="row align-items-start border-bottom-1 brd-grey-700"> <div class="col-xs-12 col-sm-3"> <h5 class="mt-2">Quick Links</h5> <nav class="nav flex-column"> <a class="nav-link grey-100 pl-0 py-1" href="https://www.alliedacademies.org/">Home</a> <a class="nav-link grey-100 pl-0 py-1" href="https://www.alliedacademies.org/journals.php">Open Acces Journals</a> <a class="nav-link grey-100 pl-0 py-1" href="https://www.alliedacademies.org/journal-submission-instructions.php">Submission Instructions</a> <a class="nav-link grey-100 pl-0 py-1" href="https://www.alliedacademies.org/publication-guidelines.php">Publication Guidelines</a> <a class="nav-link grey-100 pl-0 py-1" href="https://www.alliedacademies.org/contact.php">Contact</a> </nav> </div> <div class="col-xs-12 col-sm-3"> <h5 class="mt-2">Reach Us</h5> <address> Allied Academies<br> 40 Bloomsbury Way<br> Lower Ground Floor<br> London, United Kingdom<br> WC1A 2SE </address> </div> <div class="col-xs-12 col-sm-2"> <h5 class="mt-2">Contact Us</h5> <p> Call: 44 2033180199<br> E-Mail: <a href="mailto:info@alliedacademies.org" class="grey-100">info@alliedacademies.org</a> </p> </div> <div class="col-xs-12 col-sm-3"> <h5 class="mt-2 text-center">Follow Us</h5> <ul class="list-inline mb-0 text-center"> <li class="animate-icon list-inline-item mt-0"> <a href="https://www.facebook.com/alliedacdemies/" class="animate-icon-wrap animate-icon-sm bg-facebook-hover rounded-circle" target="_blank" title="Facebook"> <i class="animate-icon-item fab fa-facebook-f white"></i> <i class="animate-icon-item fab fa-facebook-f white"></i> </a> </li> <li class="animate-icon list-inline-item mt-0"> <a href="https://twitter.com/AlliedAcadamies" class="animate-icon-wrap animate-icon-sm white bg-twitter-hover rounded-circle" target="_blank" title="Twitter"> <i class="animate-icon-item fab fa-twitter"></i> <i class="animate-icon-item fab fa-twitter"></i> </a> </li> <li class="animate-icon list-inline-item mt-0"> <a href="https://www.linkedin.com/company/allied-academies" class="animate-icon-wrap animate-icon-sm white bg-linkedin-hover rounded-circle" target="_blank" title="Linkedin"> <i class="animate-icon-item fab fa-linkedin-in"></i> <i class="animate-icon-item fab fa-linkedin-in"></i> </a> </li> <li class="animate-icon list-inline-item mt-0"> <a href="https://www.instagram.com/allied_academies9/" class="animate-icon-wrap animate-icon-sm white bg-instagram-hover rounded-circle" target="_blank" title="Instagram"> <i class="animate-icon-item fab fa-instagram"></i> <i class="animate-icon-item fab fa-instagram"></i> </a> </li> </ul> </div> </div> <div class="row"> <div class="col"> <p class="my-3">© Allied Academies 2024 | Creative Commons License Open Access Journals by Allied Academies is licensed under a Creative Commons Attritbution 4.0 International License</p> </div> </div> </div> </footer> <div class="app-view"> Get the App <p><a href="https://play.google.com/store/apps/details?id=com.journals.alliedacademies" target="_blank"> <i class="fab fa-android"></i></a></p> </div>    <script src="https://code.jquery.com/jquery-3.3.1.min.js"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/jqueryui/1.12.1/jquery-ui.js"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.3/umd/popper.min.js"></script> <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/js/bootstrap.min.js"></script>  <script src="/assets/js/scroll-to-top.js"></script> <script> $(function () { $('[data-toggle="tooltip"]').tooltip() }) </script>  <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> <script language="javascript"> $( "#search_key" ).autocomplete({ source: function(request, response) { $.ajax({ url: "https://www.alliedacademies.org/author_names.php", type: "POST", dataType: "json", data: { keyword: request.term, }, success: function( data ) { response( data ); } }); }, select: function (event, ui) { $("#search_key").val(ui.item.value); $("#keyword").val(ui.item.id); location.href = 'https://www.alliedacademies.org/search-results.php?keyword='+encodeURI(ui.item.value); }, change: function (event, ui) { var titletext = $('#search_key').val(); if(titletext == ""){ $('#keyword').val(''); } }, minLength: 2, max:50, highlightClass: "bold-text", scroll:true }); </script> <script type="text/javascript" src="https://www.alliedacademies.org/js/jquery.back-to-top.js"></script> <script type="text/javascript" src="https://www.alliedacademies.org/js/dzsparallaxer.js"></script> <script src="//cdnjs.cloudflare.com/ajax/libs/metisMenu/2.7.7/metisMenu.min.js"></script>  <script> $("#menu").metisMenu({ triggerElement: '.nav-link', parentTrigger: '.nav-item', subMenu: '.nav.flex-column' }); </script>  </body> </html>